Neonatal abstinence syndrome: Presentation and treatment considerations

Karol Kaltenbach, Hendree E. Jones

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


The increase in opioid use among the general population is reflected in pregnant women and neonatal abstinence syndrome (NAS) statistics. This increase has produced an unprecedented focus on NAS from both the political-judicial sphere and the medical community. Under the banner of fetal protection, judges and prosecutors have implemented punitive approaches against women who use prescribed and nonprescribed opioids during pregnancy, including arrest, civil commitment, detention, prosecution, and loss of custody or termination of parental rights. Within the medical community, questions have been raised regarding protocols to detect prenatal drug exposure at delivery, NAS treatment protocols, the need for quality-improvement strategies to standardize care and reduce length of stay for mother and infant, and the benefits of engaging the mother in the care of her infant. It is not uncommon for the expression of strong discordant views on these issues both between and among these political-judicial and medical constituencies. Closely examining the issues often reveal a lack of understanding of substance use disorders, their treatment, and the occurrence and treatment of NAS. This study provides an in-depth examination of NAS, including variations in presentation and factors that impact the efficacy of treatment, and also identifying questions that remain unanswered. Finally, 4 key areas on which future research should focus to guide both medical care and public policy are discussed.

Original languageEnglish (US)
Pages (from-to)217-223
Number of pages7
JournalJournal of Addiction Medicine
Issue number4
StatePublished - Aug 1 2016


  • neonatal abstinence syndrome
  • public policy
  • treatment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)


Dive into the research topics of 'Neonatal abstinence syndrome: Presentation and treatment considerations'. Together they form a unique fingerprint.

Cite this